Recent insights into HIV accessory proteins

被引:10
作者
Jenny L. Anderson
Thomas J. Hope
机构
[1] Dept. of Microbiology and Immunology, University of Illinois at Chicago, Chicago
基金
美国国家卫生研究院;
关键词
Human Immunodeficiency Virus Type; Long Terminal Repeat; Restrictive Cell; Dileucine Motif; Viral Infectivity Factor;
D O I
10.1007/s11908-003-0024-8
中图分类号
学科分类号
摘要
HIV produces structural, regulatory, and accessory proteins during viral replication in host cells. The accessory proteins include Nef, viral infectivity factor (Vif), viral protein R, and viral protein U or viral protein X. Although these accessory proteins are generally dispensable for viral replication in vitro, they are essential for viral pathogenesis in vivo. Consequently, there has been much interest in understanding how these accessory proteins function because this research may yield new antiviral targets to curb HIV pathogenesis in vivo. Therefore, this review highlights recent advances in understanding the HIV accessory proteins and emphasizes breakthrough insights into the elusive Vif protein and potential new targets for therapeutic intervention. Copyright © 2003 by Current Science Inc.
引用
收藏
页码:439 / 450
页数:11
相关论文
共 99 条
[1]  
Hahn B.H., Shaw G.M., De Cock K.M., Sharp P.M., AIDS as a zoonosis: Scientific and public health implications, Science, 287, pp. 607-614, (2000)
[2]  
Strebel K., Daugherty D., Clouse K., Et al., The HIV 'A' (sor) gene product is essential for virus infectivity, Nature, 328, pp. 728-730, (1987)
[3]  
Lake J., Carr J., Feng F., Et al., The role of Vif during HIV-1 infection: Interaction with novel host cellular factors, J. Clin. Virol., 26, pp. 143-152, (2003)
[4]  
Simon J.H., Miller D.L., Fouchier R.A., Malim M.H., Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function, Virology, 248, pp. 182-187, (1998)
[5]  
Kao S., Akari H., Khan M.A., Et al., Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection, J. Virol., 77, pp. 1131-1140, (2003)
[6]  
Bour S., Strebel K., HIV accessory proteins: Multifunctional components of a complex system, Adv. Pharmacol., 48, pp. 75-119, (2000)
[7]  
von Schwedler U., Song J., Aiken C., Trono D., Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells, J. Virol., 67, pp. 4945-4955, (1993)
[8]  
Goncalves L., Silva F., Freitas-Vieira A., Et al., Function neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse trancscription and viral replication, J. Biol. Chem., 277, pp. 32036-32045, (2002)
[9]  
Madani N., Millete R., Platt E.J., Et al., Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1, J. Virol., 76, pp. 11133-11138, (2002)
[10]  
Li L., Olvera J.M., Yoder K.E., Et al., Role of the non-homologous DNA end joining pathaway in the early steps of retroviral infection, EMBO J., 20, pp. 3272-3281, (2001)